Thoracic Research and Practice
Clinical Study

Oxidative Stress and Products of Nitric Oxide Metabolism in Chronic Obstructive Pulmonary Disease and in Healthy Smokers

1.

Department of Chest Disease, Faculty of Medicine University, Mersin, Turkey

2.

Department of Biochemist, Faculty of Medicine University, Mersin, Turkey

3.

T. Yüksek İhtisas Education and Research Hospital, Ankara, Turkey

Thorac Res Pract 2002; 3: Turkish Respiratory Journal 24-27
Keywords : nitric oxide, COPD, smoking
Read: 624 Downloads: 372 Published: 08 October 2021

Purpose: The aim of our study was to determine whether markers of NO metabolism in serum nitrite/nitrate are increased in subjects with chronic obstructive pulmonary disease and whether they correlate with oxidant/antioxidant system markers, which are erythrocyte reduced glutathione, malondyaldehyde, vitamin C and pulmonary function tests. The relationship of these markers with smoking was also assessed.

Materials and Methods: Two groups of patients with clinically stable (n=25) and exacerbated (n=24) chronic obstructive pulmonary disease were studied. Two control groups consisting of 18 current smoker and 20 non-smoker healthy subjects were also included in the study. Serum nitrite/nitrate, malondyaldehyde, erythrocyte reduced glutathione and vitamin C levels were measured in venous blood in all sub­jects. 

Results: Mean levels of serum nitrite/nitrate in patients with chronic obstructive pulmonary disease (23.53±9.03 pmol/L) were significantly lower than in healthy control group (72.31±17.45 pmol/L). Nitrite/nitrate levels were significantly lower in healthy smokers (67.00± 14-20 pmol/L) than in healthy non-smokers (77.05± 19.03 pmol/L).

Conclusion: We found that NO metabolism was not increased in patients with chronic obstructive pulmonary disease com­pared to healthy subjects.

Files
EISSN 2979-9139